ResearchMoz

Global Human Vaccines Market 2011-2015

Publisher Name » Technavio
Published Date » 2012-06-13
No. Of Pages » 42

TechNavio's analysts forecast the Global Human Vaccines market to reach US$57.6 billion by 2015. One of the key factors contributing to this market growth is the increase in demand for vaccination against communicable diseases. The Global Human Vaccines market has also been witnessing the increase in awareness programs worldwide. However, emergence of vaccine-resistant viruses could pose a challenge to the growth of this market.

TechNavio's report, the Global Human Vaccines Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Human Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include GlaxoSmithKline plc, Merck and Co. Inc., Pfizer Inc., and Sanofi S.A. Other vendors mentioned in the report:: ALK Abello A/S, AstraZeneca plc, Bavarian Nordic A/S, Baxter International Inc., CSL Ltd., MedImmune Inc., Novartis AG, Shanta Biotechnics Ltd., Sinovac Biotech Ltd., and Vaxin Inc.

Key questions answered in this report:

  • What will the market size be in 2015 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?
  • You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of Content

1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Key Products

4. Market Landscape
Market Size
Market Segmentation by Vaccine Application
Market Segmentation by Consumers
Market Size of Global Pediatric Vaccines Market
Five Forces Analysis

5. Geographical Segmentation

6. Key Leading Countries
USA
Germany
France
UK

7. Rate of Incidence and Prevalence

8. Vendor Landscape

9. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact
Drivers and their Impact: End-users
Drivers and their Impact: Geography

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis
15.1 GlaxoSmithKline plc
Business Overview
SWOT Analysis
15.2 Sanofi S.A.
Business Overview
SWOT Analysis 32
15.3 Pfizer Inc.
Business Overview
SWOT Analysis
15.4 Merck and Co. Inc.
Business Overview
SWOT Analysis

16. Other Reports in this Series

List of Tables


Exhibit 1: Global Human Vaccines Market 2011-2015 (US$ billion)
Exhibit 2: Global Human Vaccines Market Segmentation
Exhibit 3: Global Human Vaccines Market Segmentation by Application 2011
Exhibit 4: Global Human Vaccines Market Segmentation by Consumers 2011
Exhibit 5: Global Pediatric Vaccines Market 2011-2015 (US$ billion)
Exhibit 6: Global Human Vaccines Market by Geographical Segmentation 2011
Exhibit 7: Hepatitis C Infection by Source in 2011
Exhibit 8: Global Human Vaccines Market by Vendor Segmentation 2011

List of Figures

NA

Upcoming Reports:

Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent regulation from governments of many countries is opening up new growth opportunities for less toxic biopesticides.  Increasing health awareness is giving rise to the new trend of organic food consumption, thus boosting the demand for biopesticides. Moreover, increasing...
Natural Gas-Fired Electricity Generation Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Demand for power generation has grown immensely with tremendous growth in the world population and the consequent need to fulfill the ever-increasing demands. Fossil fuels are proving insufficient in meeting the increasing demand for energy and hence there is a need to look out for substitute energy resources. Natural gas is the best alternative that can be used for generation of electricity. The natural gas-fired electricity generation market is growing rapidly as it offers a number of advantages over other fossil fuels. Use of gas-fired power generation technology is enhancing...
Natural Colorants Market - Global Industry Trends, Market Share, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Natural colors are types of food additives which are extracted from natural sources and added in food to improve its taste and appearance. Colorants are used to enhance the color of a product, to restore the color lost during processes, to standardize the color and its appearance and to increase acceptability of food. Food is the largest application segment for natural colorants with over 32% market share, followed by soft drinks and alcoholic beverages. The colors market is estimated at $1.8 billion in 2010, and natural colors market is estimated at $.66 billion of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...